Effects of Lecanemab in Chinese Patients with Early Alzheimer's Disease: Evidence from a Multidimensional Real‐World Study
These findings highlight the safety and therapeutic potential of lecanemab in Chinese patients with early AD. Further studies with larger cohorts and longer follow-up are needed to elucidate its mechanisms and disease-modifying effects.
Authors
- Xiaoyan Li (ORCID: https://orcid.org/0000-0002-8874-5634)
- Peijian Huang
- Chao Gao (ORCID: https://orcid.org/0000-0002-7954-024X)
- Jun Liu
- Wenyan Kang
Institutions
- Ruijin Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108201
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00